Literature DB >> 25559621

Is DUBA putting the brake on Th17 cells?

Anne Brüstle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559621     DOI： 10.1038/icb.2014.111

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  8 in total

1.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

Review 2.  Th17 cells in inflammation and autoimmunity.

Authors:  Ram Pyare Singh; Sascha Hasan; Sherven Sharma; Saranpreet Nagra; Dean T Yamaguchi; David T W Wong; Bevra H Hahn; Awlad Hossain
Journal:  Autoimmun Rev       Date:  2014-08-23       Impact factor: 9.754

Review 3.  Targeting Th17 cells in autoimmune diseases.

Authors:  Jianfei Yang; Mark S Sundrud; Jill Skepner; Tetsuya Yamagata
Journal:  Trends Pharmacol Sci       Date:  2014-08-14       Impact factor: 14.819

4.  Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells.

Authors:  Sascha Rutz; Nobuhiko Kayagaki; Qui T Phung; Celine Eidenschenk; Rajkumar Noubade; Xiaoting Wang; Justin Lesch; Rongze Lu; Kim Newton; Oscar W Huang; Andrea G Cochran; Mark Vasser; Benjamin P Fauber; Jason DeVoss; Joshua Webster; Lauri Diehl; Zora Modrusan; Donald S Kirkpatrick; Jennie R Lill; Wenjun Ouyang; Vishva M Dixit
Journal:  Nature       Date:  2014-12-03       Impact factor: 49.962

5.  The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.

Authors:  Anne Brüstle; Dirk Brenner; Christiane B Knobbe; Philipp A Lang; Carl Virtanen; Brian M Hershenfield; Colin Reardon; Sonja M Lacher; Jürgen Ruland; Pamela S Ohashi; Tak W Mak
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

6.  Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.

Authors:  Kamran Ghoreschi; Arian Laurence; Xiang-Ping Yang; Cristina M Tato; Mandy J McGeachy; Joanne E Konkel; Haydeé L Ramos; Lai Wei; Todd S Davidson; Nicolas Bouladoux; John R Grainger; Qian Chen; Yuka Kanno; Wendy T Watford; Hong-Wei Sun; Gérard Eberl; Ethan M Shevach; Yasmine Belkaid; Daniel J Cua; Wanjun Chen; John J O'Shea
Journal:  Nature       Date:  2010-10-21       Impact factor: 49.962

7.  Control of TH17 cells occurs in the small intestine.

Authors:  Enric Esplugues; Samuel Huber; Nicola Gagliani; Anja E Hauser; Terrence Town; Yisong Y Wan; William O'Connor; Anthony Rongvaux; Nico Van Rooijen; Ann M Haberman; Yoichiro Iwakura; Vijay K Kuchroo; Jay K Kolls; Jeffrey A Bluestone; Kevan C Herold; Richard A Flavell
Journal:  Nature       Date:  2011-07-17       Impact factor: 49.962

8.  Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.

Authors:  Katharina M Jeltsch; Desheng Hu; Sven Brenner; Jessica Zöller; Gitta A Heinz; Daniel Nagel; Katharina U Vogel; Nina Rehage; Sebastian C Warth; Stephanie L Edelmann; Renee Gloury; Nina Martin; Claudia Lohs; Maciej Lech; Jenny E Stehklein; Arie Geerlof; Elisabeth Kremmer; Achim Weber; Hans-Joachim Anders; Ingo Schmitz; Marc Schmidt-Supprian; Mingui Fu; Helmut Holtmann; Daniel Krappmann; Jürgen Ruland; Axel Kallies; Mathias Heikenwalder; Vigo Heissmeyer
Journal:  Nat Immunol       Date:  2014-10-05       Impact factor: 25.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.